Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:

Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)

First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)

Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11)

Beyond the Guidelines Survey (35:36)

Faculty Case Presentations (51:27)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.